Choi, Y.K.; Kim, J.; Lee, K.M.; Choi, Y.-J.; Ye, B.-R.; Kim, M.-S.; Ko, S.-G.; Lee, S.-H.; Kang, D.-H.; Heo, S.-J.
Tuberatolide B Suppresses Cancer Progression by Promoting ROS-Mediated Inhibition of STAT3 Signaling. Mar. Drugs 2017, 15, 55.
https://doi.org/10.3390/md15030055
AMA Style
Choi YK, Kim J, Lee KM, Choi Y-J, Ye B-R, Kim M-S, Ko S-G, Lee S-H, Kang D-H, Heo S-J.
Tuberatolide B Suppresses Cancer Progression by Promoting ROS-Mediated Inhibition of STAT3 Signaling. Marine Drugs. 2017; 15(3):55.
https://doi.org/10.3390/md15030055
Chicago/Turabian Style
Choi, Youn Kyung, Junseong Kim, Kang Min Lee, Yu-Jeong Choi, Bo-Ram Ye, Min-Sun Kim, Seong-Gyu Ko, Seung-Hong Lee, Do-Hyung Kang, and Soo-Jin Heo.
2017. "Tuberatolide B Suppresses Cancer Progression by Promoting ROS-Mediated Inhibition of STAT3 Signaling" Marine Drugs 15, no. 3: 55.
https://doi.org/10.3390/md15030055
APA Style
Choi, Y. K., Kim, J., Lee, K. M., Choi, Y.-J., Ye, B.-R., Kim, M.-S., Ko, S.-G., Lee, S.-H., Kang, D.-H., & Heo, S.-J.
(2017). Tuberatolide B Suppresses Cancer Progression by Promoting ROS-Mediated Inhibition of STAT3 Signaling. Marine Drugs, 15(3), 55.
https://doi.org/10.3390/md15030055